P-1423 - NOCOMIT-J: a community intervention trial of multi-modal suicide prevention program in Japan - 13/06/12
J-MISP group
Résumé |
Objective |
The primary goal of this study is to examine the effectiveness of a community-based multimodal intervention program for suicide prevention in regions where the suicide rate was relatively high compared to control regions. The secondary goal was to explore the effectiveness of a community-based multimodal intervention program for suicide prevention in highly populated regions.
Methods/design |
NOCOMIT-J is a community-based large-scale non-randomized controlled trial, involving seven intervention regions with accompanying control regions, all with populations of statistically sufficient size. The program consists of
1) | establishing social support networks in the public health system for suicide prevention and mental health promotion; |
2) | a primary prevention measures of awareness campaign for the public and key personnel; |
3) | secondary prevention measures for screening, counseling and outreach services for high-risk individuals; |
4) | after-care for individuals bereaved by suicide; |
5) | suicide prevention measures especially for individuals with mental illness and work-related problems. |
This study protocol was reviewed and approved by the Central Ethics Committee of the J-MISP. Additionally, the regional leaders obtained written authorization from the local governors.
Results/progress |
The intervention started in July 2006, and continued for 3.5 years. Participants are Japanese and foreign residents living in the intervention and control regions, a total of population of 2,120,000 individuals.
Discussion |
Because treatment and prevention of suicide are complex and encompass many factors, success will need multi-sector collaboration. We hope that the results of NOCOMIT-J will help to develop effective strategies to reduce future suicide rate. (ClinicalTrials.gov: NCT00737165)
Le texte complet de cet article est disponible en PDF.Vol 27 - N° S1
P. 1 - 2012 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?